Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Clopidogrel 75 mg Film-coated Tablets in Healthy Thai Volunteers
TCTR20260715005Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of clopidogrel in myocardial infarction (MI), ischemic stroke, arteriosclerosis obliterans and 1 more (2 arms), sponsored by International Bio Service. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
clopidogrel
03
Conditions
myocardial infarction (MI)ischemic strokearteriosclerosis obliteranscoronary arteriosclerosis
Beyond the preview
Go deeper on TCTR20260715005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260715005.